U.S. Assisted Reproductive Technology Market - Industry Outlook & Forecast 2022-2027

U.S. Assisted Reproductive Technology Market - Industry Outlook & Forecast 2022-2027

The U.S. Assisted Reproductive Technology Market Report contains a Detailed Overview of the Vendor Landscape, Competitive Analysis, And Critical Market Strategies to Gain Competitive Advantage

Increasing prevalence of infertility, rising number of fertility clinics offering fertility services, changing lifestyle of people leading to infertility, increasing acceptance of ART procedure are some of the factors driving the market growth during the forecast period.

The U.S. assisted reproductive technology (ART) market is expected to grow at a CAGR of 6.90% during the forecast period.

GLOBAL U.S. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SEGMENTATION

Other factors such as increased number of ART device manufacturing companies, growing investments by private & public players, and increasing financial assistance programs are also contributing to the growth of overall assisted reproductive technology market. However, high cost of infertility treatment and risk associated with in vitro fertilization treatment are expected to restrict the market growth during the forecast period.

Segmentation by Type

  • Services
  • Source
  • Frozen Non-Donor
  • Fresh Non-Donor
  • Fresh Donor
  • Frozen Donor
  • Age Group
  • Between 35 & 40 Years
  • Less Than 35 Years
  • Above 40 Years
  • Technique
  • In Virto Fertilization (IVF)
  • Frozen Embryo Transfer (FET)
  • Others
  • Devices
  • Product
  • Consumables
  • Media
  • Equipment
  • End-user
  • Fertility Clinics
  • Hospitals
VENDOR ANALYSIS

The Cooper Companies, Cook Medical and Vitrolife are the major players in the US assisted reproductive technology market. The market also has several regional players that are competing with the global players in terms of new product launch.

The key vendors in the market include the Cooper companies, Cook Medical, FUJIFILM Irvine Scientific, Hamilton Throne, Merck KGaA, and Vitrolife. With the rising demand for infertility treatment in the US, the market share of these vendors is expected to grow in the coming years. However, the major players are facing stiff competition from emerging players.

Vendors are progressively focusing on introducing innovative devices to penetrate and utilize the huge growth potential prevailing in the market. The technological advancements and innovations in the field of ART is providing tremendous growth opportunity to the vendors.

Key Manufacturers Profile
  • The Cooper Companies
  • Cook Medical
  • FUJIFILM Irvine Scientific
  • Hamilton Thorne
  • Merck Group
  • Vitrolife
Other Prominent Manufacturers
  • CARL ZEISS
  • Esco Lifesciences
  • INVO Bioscience
  • Kitazato USA
  • Nidacon
  • Rocket Medical
  • Thermo Fisher Scientific
  • Thomas Medical
Prominent Art Service Providers
  • The American Fertility California Corp.
  • Angels Creation Reproductive Center (ACRC)
  • Aspire Houston Fertility Institute
  • Boston IVF
  • CARE Fertility
  • Carolinas Fertility Institute
  • CCRM Fertility
  • Center of Reproductive Medicine
  • Conceptions Reproductive Associates
  • Dallas-Fort Worth Fertility Associates
  • Extend Fertility
  • Fertility Center
  • Fertility Center of San Antonio
  • Infertility Texas
  • Innovative Fertility Center
  • Institute for Human Reproduction (IHR)
  • Kindbody
  • Main Line Fertility & Reproductive Medicine
  • Mayo Clinic
  • New Hope Fertility Center
  • Oma Fertility
  • Overlake Reproductive Health
  • Pacific Fertility Center
  • Pacific Reproductive Center
  • Reproductive Medicine Associates of Philadelphia
  • ReproMed Fertility Center
  • San Diego Fertility Center
  • Santa Barbara Fertility Center
  • Santa Monica Fertility
  • Sher Institutes for Reproductive Medicine
  • Southern California Reproductive Center (SCRC)
  • Tennessee Reproductive Medicine (TRM)
  • Texas Center for Reproductive Health
  • The Center for Fertility and Gynecology
  • The Fertility Center of Las Vegas
  • The Reproductive Medicine Group
  • UCLA Fertility and Reproductive Health Center
  • Western Fertility Institute
  • Wisconsin Fertility
THE REPORT INCLUDES:

1. The analysis of the U.S. Assisted Reproductive Technology market size and growth rate for the forecast period 2022-2027.

2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the U.S. Assisted Reproductive Technology market.

3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.

4. It offers a complete overview of market segments and the regional outlook of the Assisted Reproductive Technology market.


1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY SERVICE
4.3.2 MARKET SEGMENTATION BY DEVICE
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW OF INFERTILITY & ART
7.2 TRENDS IN ART
8 MARKET OPPORTUNITIES & TRENDS
8.1 GROWING NUMBER OF SINGLE PARENTS AND SAME-SEX COUPLES
8.2 TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN ART
8.3 RISING VENTURE CAPITAL & PRIVATE EQUITY INVESTMENTS IN INFERTILITY SERVICES
8.4 INCREASING FINANCIAL ASSISTANCE PROGRAMS & EMPLOYER BENEFITS FOR INFERTILITY TREATMENT
9 MARKET GROWTH ENABLERS
9.1 INCREASING PREVALENCE OF INFERTILITY
9.2 RISING NUMBER OF FERTILITY CLINICS OFFERING FERTILITY SERVICES
9.3 CHANGING LIFESTYLES OF PEOPLE
9.4 INCREASING ACCEPTANCE OF ART PROCEDURES
10 MARKET RESTRAINTS
10.1 HIGH COST OF INFERTILITY TREATMENT
10.2 RISKS AND LIMITATIONS ASSOCIATED WITH INFERTILITY TREATMENT
10.3 ETHICAL CHALLENGES RELATED TO INFERTILITY TREATMENT
10.4 LACK OF STANDARDIZED GOVERNMENT REGULATIONS ON INFERTILITY TREATMENT
11 MARKET LANDSCAPE
11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
11.2.1 TYPE INSIGHTS
11.2.2 SOURCE INSIGHTS
11.2.3 AGE GROUP INSIGHTS
11.2.4 TECHNIQUE INSIGHTS
11.2.5 PRODUCT INSIGHTS
11.2.6 END-USER INSIGHTS
11.3 FIVE FORCES ANALYSIS
11.3.1 THREAT OF NEW ENTRANTS
11.3.2 BARGAINING POWER OF SUPPLIERS
11.3.3 BARGAINING POWER OF BUYERS
11.3.4 THREAT OF SUBSTITUTES
11.3.5 COMPETITIVE RIVALRY
12 TYPE
12.1 MARKET SNAPSHOT & GROWTH ENGINE
12.2 MARKET OVERVIEW
13 SERVICES
13.1 MARKET OVERVIEW
13.2 MARKET SIZE & FORECAST
13.3 ART SERVICES MARKET BY SOURCE
13.3.1 MARKET SNAPSHOT & GROWTH ENGINE
13.4 FROZEN NON-DONOR
13.4.1 MARKET SIZE & FORECAST
13.5 FRESH NON-DONOR
13.5.1 MARKET SIZE & FORECAST
13.6 FRESH DONOR
13.6.1 MARKET SIZE & FORECAST
13.7 FROZEN DONOR
13.7.1 MARKET SIZE & FORECAST
13.8 ART SERVICES MARKET BY AGE GROUP
13.8.1 MARKET SNAPSHOT & GROWTH ENGINE
13.9 BETWEEN 35 & 40 YEARS
13.9.1 MARKET SIZE & FORECAST
13.10 LESS THAN 35 YEARS
13.10.1 MARKET SIZE & FORECAST
13.11 ABOVE 40 YEARS
13.11.1 MARKET SIZE & FORECAST
13.12 ART SERVICES MARKET BY TECHNIQUE
13.12.1 MARKET SNAPSHOT & GROWTH ENGINE
13.13 IN VITRO FERTILIZATION (IVF)
13.13.1 MARKET SIZE & FORECAST
13.14 FROZEN EMBRYO TRANSFER (FET)
13.14.1 MARKET SIZE & FORECAST
13.15 OTHERS
13.15.1 MARKET SIZE & FORECAST
14 DEVICES
14.1 MARKET OVERVIEW
14.2 MARKET SIZE & FORECAST
14.3 ART DEVICES MARKET BY PRODUCT
14.3.1 MARKET SNAPSHOT & GROWTH ENGINE
14.3.2 CONSUMABLES: MARKET SIZE & FORECAST
14.3.3 MEDIA: MARKET SIZE & FORECAST
14.3.4 EQUIPMENT: MARKET SIZE & FORECAST
14.4 ART DEVICES MARKET BY END-USER
14.4.1 MARKET SNAPSHOT & GROWTH ENGINE
14.4.2 FERTILITY CLINICS: MARKET SIZE & FORECAST
14.4.3 HOSPITALS: MARKET SIZE & FORECAST
15 COMPETITIVE LANDSCAPE
15.1 COMPETITION OVERVIEW: ART DEVICE MANUFACTURERS
15.2 COMPETITION OVERVIEW: SERVICE PROVIDERS
15.3 MARKET SHARE ANALYSIS: MANUFACTURERS
15.3.1 THE COOPER COMPANIES
15.3.2 COOK MEDICAL
15.3.3 VITROLIFE
15.3.4 FUJIFILM IRVINE SCIENTIFIC
15.3.5 ROCKET MEDICAL
15.3.6 KITAZATO
15.3.7 MERCK GROUP
15.3.8 HAMILTON THORNE
15.4 MARKET SHARE ANALYSIS: ART SERVICE PROVIDERS
16 KEY MANUFACTURER PROFILES
16.1 THE COOPER COMPANIES
16.1.1 BUSINESS OVERVIEW
16.1.2 MAJOR PRODUCT OFFERINGS
16.1.3 KEY STRENGTHS
16.1.4 KEY STRATEGIES
16.1.5 KEY OPPORTUNITIES
16.2 COOK MEDICAL
16.2.1 BUSINESS OVERVIEW
16.2.2 MAJOR PRODUCT OFFERINGS
16.2.3 KEY STRATEGIES
16.2.4 KEY STRENGTHS
16.2.5 KEY OPPORTUNITIES
16.3 FUJIFILM IRVINE SCIENTIFIC
16.3.1 BUSINESS OVERVIEW
16.3.2 MAJOR PRODUCT OFFERINGS
16.3.3 KEY STRATEGIES
16.3.4 KEY STRENGTHS
16.3.5 KEY OPPORTUNITIES
16.4 HAMILTON THORNE
16.4.1 BUSINESS OVERVIEW
16.4.2 MAJOR PRODUCT OFFERINGS
16.4.3 KEY STRATEGIES
16.4.4 KEY STRENGTHS
16.4.5 KEY OPPORTUNITIES
16.5 MERCK GROUP
16.5.1 BUSINESS OVERVIEW
16.5.2 MAJOR PRODUCT OFFERINGS
16.5.3 KEY STRATEGIES
16.5.4 KEY STRENGTHS
16.5.5 KEY OPPORTUNITIES
16.6 VITROLIFE
16.6.1 BUSINESS OVERVIEW
16.6.2 MAJOR PRODUCT OFFERINGS
16.6.3 KEY STRATEGIES
16.6.4 KEY STRENGTHS
16.6.5 KEY OPPORTUNITIES
17 OTHER PROMINENT MANUFACTURERS
17.1 CARL ZEISS
17.1.1 BUSINESS OVERVIEW
17.1.2 MAJOR PRODUCT OFFERINGS
17.2 ESCO LIFESCIENCES
17.2.1 BUSINESS OVERVIEW
17.2.2 MAJOR PRODUCT OFFERINGS
17.3 INVO BIOSCIENCE
17.3.1 BUSINESS OVERVIEW
17.3.2 MAJOR PRODUCT OFFERINGS
17.4 KITAZATO
17.4.1 BUSINESS OVERVIEW
17.4.2 MAJOR PRODUCT OFFERINGS
17.5 NIDACON
17.5.1 BUSINESS OVERVIEW
17.5.2 MAJOR PRODUCT OFFERINGS
17.6 ROCKET MEDICAL
17.6.1 BUSINESS OVERVIEW
17.6.2 MAJOR PRODUCT OFFERINGS
17.7 THERMO FISHER SCIENTIFIC
17.7.1 BUSINESS OVERVIEW
17.7.2 MAJOR PRODUCT OFFERINGS
17.8 THOMAS MEDICAL
17.8.1 BUSINESS OVERVIEW
17.8.2 MAJOR PRODUCT OFFERINGS
18 PROMINENT ART SERVICE PROVIDERS
18.1 THE AMERICAN FERTILITY CALIFORNIA CORP.
18.1.1 BUSINESS OVERVIEW
18.2 ANGELS CREATION REPRODUCTIVE CENTER
18.2.1 BUSINESS OVERVIEW
18.3 ASPIRE HOUSTON FERTILITY INSTITUTE
18.3.1 BUSINESS OVERVIEW
18.4 BOSTON IVF
18.4.1 BUSINESS OVERVIEW
18.5 CARE FERTILITY
18.5.1 BUSINESS OVERVIEW
18.6 CAROLINAS FERTILITY INSTITUTE
18.6.1 BUSINESS OVERVIEW
18.7 CCRM FERTILITY
18.7.1 BUSINESS OVERVIEW
18.8 CENTER OF REPRODUCTIVE MEDICINE
18.8.1 BUSINESS OVERVIEW
18.9 CONCEPTIONS REPRODUCTIVE ASSOCIATES
18.9.1 BUSINESS OVERVIEW
18.10 DALLAS-FORT WORTH FERTILITY ASSOCIATES
18.10.1 BUSINESS OVERVIEW
18.11 EXTEND FERTILITY
18.11.1 BUSINESS OVERVIEW
18.12 FERTILITY CENTER
18.12.1 BUSINESS OVERVIEW
18.13 FERTILITY CENTER OF SAN ANTONIO
18.13.1 BUSINESS OVERVIEW
18.14 INFERTILITY TEXAS
18.14.1 BUSINESS OVERVIEW
18.15 INNOVATIVE FERTILITY CENTER
18.15.1 BUSINESS OVERVIEW
18.16 INSTITUTE FOR HUMAN REPRODUCTION
18.16.1 BUSINESS OVERVIEW
18.17 KINDBODY
18.17.1 BUSINESS OVERVIEW
18.18 MAIN LINE FERTILITY & REPRODUCTIVE MEDICINE
18.18.1 BUSINESS OVERVIEW
18.19 MAYO CLINIC
18.19.1 BUSINESS OVERVIEW
18.20 NEW HOPE FERTILITY CENTER
18.20.1 BUSINESS OVERVIEW
18.21 OMA FERTILITY
18.21.1 BUSINESS OVERVIEW
18.22 OVERLAKE REPRODUCTIVE HEALTH
18.22.1 BUSINESS OVERVIEW
18.23 PACIFIC FERTILITY CENTER
18.23.1 BUSINESS OVERVIEW
18.24 PACIFIC REPRODUCTIVE CENTER
18.24.1 BUSINESS OVERVIEW
18.25 REPRODUCTIVE MEDICINE ASSOCIATES OF PHILADELPHIA
18.25.1 BUSINESS OVERVIEW
18.26 REPROMED FERTILITY CENTER
18.26.1 BUSINESS OVERVIEW
18.27 SAN DIEGO FERTILITY
18.27.1 BUSINESS OVERVIEW
18.28 SANTA BARBARA FERTILITY CENTER
18.28.1 BUSINESS OVERVIEW
18.29 SANTA MONICA FERTILITY
18.29.1 BUSINESS OVERVIEW
18.30 SHER INSTITUTES FOR REPRODUCTIVE MEDICINE
18.30.1 BUSINESS OVERVIEW
18.31 SOUTHERN CALIFORNIA REPRODUCTIVE CENTER
18.31.1 BUSINESS OVERVIEW
18.32 TENNESSEE REPRODUCTIVE MEDICINE
18.32.1 BUSINESS OVERVIEW
18.33 TEXAS CENTER FOR REPRODUCTIVE HEALTH
18.33.1 BUSINESS OVERVIEW
18.34 THE CENTER FOR FERTILITY AND GYNECOLOGY
18.34.1 BUSINESS OVERVIEW
18.35 THE FERTILITY CENTER OF LAS VEGAS
18.35.1 BUSINESS OVERVIEW
18.36 THE REPRODUCTIVE MEDICINE GROUP
18.36.1 BUSINESS OVERVIEW
18.37 UCLA HEALTH
18.37.1 BUSINESS OVERVIEW
18.38 WESTERN FERTILITY INSTITUTE
18.38.1 BUSINESS OVERVIEW
18.39 WISCONSIN FERTILITY INSTITUTE
18.39.1 BUSINESS OVERVIEW
19 REPORT SUMMARY
19.1 KEY TAKEAWAYS
19.2 STRATEGIC RECOMMENDATIONS
20 QUANTITATIVE SUMMARY
20.1 MARKET BY TYPE
20.2 MARKET BY ART SERVICES
20.2.1 ART SERVICES: SOURCE SEGMENTATION
20.2.2 ART SERVICES: AGE GROUP SEGMENTATION
20.2.3 ART SERVICES: TECHNIQUE SEGMENTATION
20.3 MARKET BY ART DEVICES
20.3.1 ART DEVICES: PRODUCT SEGMENTATION
20.3.2 ART DEVICES: END-USER SEGMENTATION
21 APPENDIX
21.1 ABBREVIATIONS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings